CANSARTAN Mepha plus cpr 32/25 98 pce
7680612150121
CH-61215
C09DA06
02.07.2.
1 / 3
google
Details
- Product number
- 6121504
- CPT
- -
- Packaging group
- 98
- Unit
- Tablette(n)
- Composition
- candesartanum cilexetilum 32.00 mg, hydrochlorothiazidum 25.00 mg, maydis amylum, lactosum monohydricum 218.60 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.86 mg, magnesii stearas, pro compresso.
Articles (1)
Cansartan-Mepha plus 32/25, Tabletten
Tabletten
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
32.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
218.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.86 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 51.75
Specialties list
Yes
Generic
Yes
SL addition date:
01/11/2014
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 61215
- Drug name
- Cansartan-Mepha plus, Tabletten
- Galenic form
- TAB
- ATC Code
- C09DA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CANSARTAN Mepha plus cpr 32/25 98 pce
- Description (DE)
- CANSARTAN Mepha plus Tabl 32/25 98 Stk
- Market launch
- 05/09/2014
- Narcotic (BTM)
- No